We are live on ! Find out more
CFG

Cambridge Financial Group Portfolio holdings

AUM $267M
1-Year Est. Return 31.62%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+31.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.6M
AUM Growth
-$180M
Cap. Flow
-$185M
Cap. Flow %
-899.01%
Top 10 Hldgs %
36.07%
Holding
35
New
5
Increased
Reduced
25
Closed
5

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$670K
2
AVGO icon
Broadcom
AVGO
+$662K
3
NKE icon
Nike
NKE
+$627K
4
ABBV icon
AbbVie
ABBV
+$623K
5
ROST icon
Ross Stores
ROST
+$610K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.56M
2
GD icon
General Dynamics
GD
+$7.25M
3
ECL icon
Ecolab
ECL
+$6.99M
4
CAH icon
Cardinal Health
CAH
+$6.82M
5
LMT icon
Lockheed Martin
LMT
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 23.77%
2 Healthcare 23.33%
3 Technology 20.89%
4 Consumer Staples 12.99%
5 Consumer Discretionary 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDC icon
1
Western Digital
WDC
$188B
$770K 3.74%
9,201
-88,230
-91% -$6.66M
MS icon
2
Morgan Stanley
MS
$331B
$768K 3.74%
19,805
-187,419
-90% -$6.67M
AVGO icon
3
Broadcom
AVGO
$1.85T
$745K 3.62%
+74,050
New +$662K
LMT icon
4
Lockheed Martin
LMT
$134B
$741K 3.6%
3,850
-36,342
-90% -$6.75M
TGT icon
5
Target
TGT
$65.6B
$736K 3.58%
9,696
-91,352
-90% -$6.17M
GD icon
6
General Dynamics
GD
$104B
$734K 3.57%
5,331
-53,262
-91% -$7.25M
CAH icon
7
Cardinal Health
CAH
$53.9B
$733K 3.56%
9,077
-86,353
-90% -$6.82M
MU icon
8
Micron Technology
MU
$930B
$732K 3.56%
20,900
-201,289
-91% -$6.66M
CELG
9
DELISTED
Celgene Corp
CELG
$730K 3.55%
6,530
-59,790
-90% -$6.31M
INTC icon
10
Intel
INTC
$455B
$728K 3.54%
20,070
-188,262
-90% -$6.55M
WBA
11
DELISTED
Walgreens Boots Alliance
WBA
$718K 3.49%
9,427
-87,136
-90% -$5.83M
RTN
12
DELISTED
Raytheon Company
RTN
$718K 3.49%
6,640
-61,255
-90% -$6.32M
UNH icon
13
UnitedHealth
UNH
$376B
$706K 3.43%
6,980
-65,873
-90% -$6.24M
FDX icon
14
FedEx
FDX
$72.7B
$705K 3.43%
4,060
-38,168
-90% -$6.46M
BIIB icon
15
Biogen
BIIB
$30B
$704K 3.42%
2,075
-20,108
-91% -$6.51M
XRX icon
16
Xerox
XRX
$387M
$701K 3.41%
19,182
-181,589
-90% -$6.4M
UNP icon
17
Union Pacific
UNP
$174B
$696K 3.38%
+5,840
New +$670K
AMAT icon
18
Applied Materials
AMAT
$403B
$695K 3.38%
27,890
-254,906
-90% -$5.76M
ADM icon
19
Archer Daniels Midland
ADM
$38.2B
$685K 3.33%
13,176
-131,309
-91% -$6.55M
ROST icon
20
Ross Stores
ROST
$80.5B
$682K 3.31%
+14,460
New +$610K
META icon
21
Meta Platforms (Facebook)
META
$1.42T
$681K 3.31%
8,725
-83,169
-91% -$6.36M
BMS
22
DELISTED
Bemis
BMS
$656K 3.19%
14,510
-131,189
-90% -$5.28M
WMT icon
23
Walmart Inc
WMT
$885B
$650K 3.16%
22,716
-214,161
-90% -$5.79M
ABBV icon
24
AbbVie
ABBV
$443B
$647K 3.15%
+9,885
New +$623K
NKE icon
25
Nike
NKE
$61.9B
$642K 3.12%
+13,360
New +$627K

Similar funds

Cambridge Financial Group's Q4 2014 Portfolio in Review

As of Q4 2014, Cambridge Financial Group held 35 positions worth $20.6M, down 90% from $200M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Cambridge Financial Group withdrew a net $185M in Q4 2014, closing 5 positions and reducing 25 holdings. Its most notable exit was Ecolab, an estimated $6.99M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Cambridge Financial Group opened a new position in Union Pacific worth $696K.

  • Cambridge Financial Group's largest Q4 2014 buy was Union Pacific: 5,840 shares worth $696K.
  • Cambridge Financial Group's biggest Q4 2014 reduction was Gilead Sciences, cutting an estimated $7.56M.
  • Cambridge Financial Group fully exited Ecolab in Q4 2014, selling an estimated $6.99M.
  • Cambridge Financial Group's ten largest holdings make up 36% of its $20.6M portfolio in Q4 2014.
  • Cambridge Financial Group opened 5 new positions and closed 5 in Q4 2014.
  • Cambridge Financial Group's portfolio value fell 90% quarter-over-quarter to $20.6M.

Based on Cambridge Financial Group's 13F filing for Q4 2014, filed 4 Feb 2015.